IP Library Granted Patent US 10,045,970
Granted Patent B2
US 10,045,970 · App. 15/585,038 · Granted Aug 14, 2018

Methods of use of cyclopamine analogs

Inventors: Alfredo C. Castro (Winchester, MA); Michael J. Grogan (Winchester, MA); Karen J. McGovern (Groton, MA); Martin R. Tremblay (Melrose, MA)
Assignee: Infinity Pharmaceuticals, Inc.
A61K31/4355A61K9/0014A61K31/17A61K31/196A61K31/198A61K31/454A61K31/4745A61K31/519A61K31/56A61K31/573A61K31/58A61K31/664A61K31/69A61K31/704A61K31/7068A61K31/7076A61K38/21A61K45/06A61N5/10C07D307/94C07D471/04C07D471/10C07D491/04C07D491/048C07D491/10C07D491/107C07J69/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,045,970
App. No.
15/585,038
Granted
Aug 14, 2018
Kind
B2
Abstract

The invention provides methods for treating various conditions using derivatives of cyclopamine having the following formula:

Claims (10)

1. A method for treating basal cell carcinoma in a subject, the method comprising administering to the subject a composition comprising a compound having the structure:

or a pharmaceutically acceptable acid salt thereof, and a pharmaceutically acceptable carrier or diluent.

2. The method of claim 1 , wherein the compound is in the form of a pharmaceutically acceptable acid salt.

3. The method of claim 2 , wherein the salt is an inorganic acid salt.

4. The method of claim 2 , wherein the salt is a hydrochloric acid salt.

5. The method of claim 1 , wherein the composition is a liquid composition.

6. The method of claim 1 , wherein the composition is in the form of a cream, ointment, or spray.

7. The method of claim 1 , wherein the composition is administered topically.

8. The method of claim 1 , wherein said administering is carried out in combination with an additional cancer treatment.

9. The method of claim 8 , wherein said additional cancer treatment comprises radiation, surgery, or administration of a second chemotherapeutic agent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: INFINITY PHARMACEUTICALS, INC.
To: ROYALTY SECURITY, LLC
Reel/Frame 051519/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2017
From: CASTRO, ALFREDO C.; GROGAN, MICHAEL J.; MCGOVERN, KAREN J.; TREMBLAY, MARTIN R.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 044052/0243 →
Continuity (8)
Continuation 14841001 · Aug 31, 2015
Continuation 14054350 · Oct 15, 2013
Continuation 13475510 · May 18, 2012
Continuation 13090694 · Apr 20, 2011
Continuation 11965675 · Dec 27, 2007
Provisional Application 60941596 · Jun 1, 2007
Provisional Application 60878018 · Dec 28, 2006
Related Publication 20170360763A1 · Dec 21, 2017
Cited By (1)
US 12,245,355